Stay updated on CD22-Positive ALL Treatment: Inotuzumab vs Blinatumomab Clinical Trial
Sign up to get notified when there's something new on the CD22-Positive ALL Treatment: Inotuzumab vs Blinatumomab Clinical Trial page.

Latest updates to the CD22-Positive ALL Treatment: Inotuzumab vs Blinatumomab Clinical Trial page
- CheckyesterdayChange DetectedAdded several new history entries (versions 312–316) to the Record History, documenting updates to Contacts/Locations and Study Status.SummaryDifference0.2%

- Check8 days agoChange DetectedAdded new sections for Study Status, Study Design, Study Description, and Contacts/Locations; entries 310 and 311 were added, and the 2026-03-12 entry was removed.SummaryDifference0.1%

- Check15 days agoChange DetectedThe site revision was updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check22 days agoChange DetectedAdded history entries for versions 306–309, documenting updates to Study Status and Contacts/Locations dated 2026-03-07 to 2026-03-12.SummaryDifference0.2%

- Check29 days agoChange DetectedAdded 2026-03-03 to 2026-03-06 Study Status entries and Revision: v3.4.3; removed Revision: v3.4.2.SummaryDifference0.3%

- Check37 days agoChange DetectedNew history entries were added showing updates to the Study Status and new version numbers (296–300) for the record.SummaryDifference0.2%

Stay in the know with updates to CD22-Positive ALL Treatment: Inotuzumab vs Blinatumomab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CD22-Positive ALL Treatment: Inotuzumab vs Blinatumomab Clinical Trial page.